Outcome and factors associated with mortality in patients receiving urgent chemotherapy in the ICU: A retrospective study.

[1]  C. June,et al.  Engineered cellular immunotherapies in cancer and beyond , 2022, Nature Medicine.

[2]  Qunfang Wan,et al.  Management strategy for hematological malignancy patients with acute respiratory failure , 2021, European Journal of Medical Research.

[3]  M. Paesmans,et al.  Initiation of a new anti-cancer medical treatment in ICU: a retrospective study , 2021, Acta clinica Belgica.

[4]  J. Timsit,et al.  Factors associated with survival of patients with solid Cancer alive after intensive care unit discharge between 2005 and 2013 , 2021, BMC Cancer.

[5]  F. D. Martos-Benítez,et al.  Critically ill patients with cancer: A clinical perspective , 2020, World journal of clinical oncology.

[6]  F. Bozza,et al.  Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study , 2020, Intensive Care Medicine.

[7]  J. Ferreira,et al.  Impact of Urgent Chemotherapy in Critically Ill Patients , 2020, Journal of intensive care medicine.

[8]  A. Ravaud,et al.  Long-term prognosis of septic shock in cancer patients , 2019, Supportive Care in Cancer.

[9]  J. Vincent,et al.  Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis , 2019, Critical Care.

[10]  Jimmy Ruiz,et al.  Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. , 2019, Journal of geriatric oncology.

[11]  T. Similowski,et al.  Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs) , 2018, Annals of Intensive Care.

[12]  E. P. Herrejón,et al.  Pacientes oncológicos ingresados en Unidad de Cuidados Intensivos. Análisis de factores predictivos de mortalidad , 2018, Medicina Intensiva.

[13]  J. Tamburini,et al.  Urgent Chemotherapy in Sepsis-Like Shock Related to Hematologic Malignancies , 2018, Critical care medicine.

[14]  H. Kluin-Nelemans,et al.  Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units , 2018, British journal of haematology.

[15]  M. Antonelli,et al.  The Intensive Care Medicine research agenda on critically ill oncology and hematology patients , 2017, Intensive Care Medicine.

[16]  É. Azoulay,et al.  Managing critically Ill hematology patients: Time to think differently. , 2015, Blood reviews.

[17]  L. Azevedo,et al.  Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study. , 2014, Chest.

[18]  K. Laczika,et al.  Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit , 2014, Annals of Hematology.

[19]  S. Chevret,et al.  Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  T. Lisboa,et al.  Critically ill patients with cancer and sepsis: clinical course and prognostic factors. , 2012, Journal of critical care.

[21]  Keunchil Park,et al.  Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit , 2011, Supportive Care in Cancer.

[22]  C. Ferreira,et al.  Prognosis of lung cancer patients with life-threatening complications. , 2007, Chest.

[23]  J. le Gall,et al.  Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy* , 2005, Critical care medicine.

[24]  É. Azoulay,et al.  Improved survival of critically ill cancer patients with septic shock , 2003, Intensive Care Medicine.

[25]  M. Rosenthal,et al.  Outcome of patients admitted to the intensive care unit with newly diagnosed small cell lung cancer. , 2002, Lung cancer.

[26]  J. Jamart,et al.  Prognosis of hematologic malignancies does not predict intensive care unit mortality , 2002, Critical care medicine.

[27]  R. Schilsky,et al.  Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Decruyenaere,et al.  Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  B. Afessa,et al.  The intensive care support of patients with malignancy: do everything that can be done , 2005, Intensive Care Medicine.

[30]  J. Decruyenaere,et al.  Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit , 2005, Intensive Care Medicine.